Epidermal Growth Factor Receptor Inhibitor Database
|
|
|
|
|
|
|
|
|
|
|
| Compound Details | |||||
| S.No. | Molceule ID (DB) | Molecule_name | VANDER SURFACE AREA 3D(+/- 5) | ||
| 1 | EGIN0000161 | Doxorubicin | 713.49 | ||
| 2 | EGIN0000530 | 3a | 717.66 | ||
| 3 | EGIN0000548 | 20 | 714.97 | ||
| 4 | EGIN0000563 | 35 | 717.7 | ||
| 5 | EGIN0001030 | 1q | 718.05 | ||
| 6 | EGIN0001147 | 21 | 709.6 | ||
| 7 | EGIN0001365 | 12b | 713.45 | ||
| 8 | EGIN0001614 | 9 | 713.16 | ||
| 9 | EGIN0001622 | 15e | 717.62 | ||
| 10 | EGIN0001842 | 7 | 716.2 | ||
| 11 | EGIN0001896 | 20 | 717.69 | ||
| 12 | EGIN0001987 | 12l | 717.44 | ||
| 13 | EGIN0001991 | 12p | 713.83 | ||
| 14 | EGIN0002321 | 22 | 716.26 | ||
| 15 | EGIN0002476 | PQIP | 717.49 | ||
| 16 | EGIN0002652 | 10h | 712.26 | ||
| 17 | EGIN0002995 | 1 | 713.87 | ||
| 18 | EGIN0003012 | 26c | 719.08 | ||
| 19 | EGIN0003019 | 26j | 710.68 | ||
| 20 | EGIN0003113 | 28 | 717.59 | ||
| 21 | EGIN0003160 | 4 | 713.5 | ||
| 22 | EGIN0003314 | 8c | 710.42 | ||
| 23 | EGIN0003493 | 19c | 711.4 | ||
| 24 | EGIN0003548 | AG573 | 713.19 | ||
| 25 | EGIN0003922 | 5q | 710.54 | ||
| 26 | EGIN0004093 | 1j | 716.65 | ||
| 27 | EGIN0004194 | 11 | 713.9 | ||
| 28 | EGIN0004294 | 12 | 716 | ||
| 29 | EGIN0004359 | WZ4003 | 717.19 | ||
| 30 | EGIN0004516 | 3r | 717.7 | ||
| 31 | EGIN0004521 | 3l | 711.39 | ||
| 32 | EGIN0004524 | 3i (reversiable) | 717.79 | ||
| 33 | EGIN0004554 | 2n | 716.25 | ||
| 34 | EGIN0004559 | 2i | 710.78 | ||
| 35 | EGIN0004566 | 2d | 718.97 | ||
| 36 | EGIN0004829 | 7 | 714.12 | ||